PATENT CLAIM ANALYSIS

Application Number: 15744734
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
Provided are anti-GM-CSF antibodies or fragments thereof including humanized antibodies and fragments. Also provided are uses of the antibodies and fragments for therapeutic, diagnostic and prognostic purposes. Therapeutic uses of the antibodies and fragments, for example include the treatment of inflammatory and autoimmune diseases and disorders.

Claim (Index 11):
The antibody or fragment thereof of  claim 7 , comprising a light chain variable region comprising one or more amino acid residues selected from the group consisting of:\n (a) Ala at position 46, (b) Asp at position 60, (c) Asp at position 70, (d) Ser at position 43, and (f) Phe at position 87, according to Kabat numbering, and combinations thereof.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 86.0
- Lexical Diversity: 1.7
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11918368', '14718923', '12681396', '12766444', '13988498']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7567635432574958
- 35 USC 102 Novelty (BERT): 0.5368623072228722
- Combined Prediction Score: 0.7347734196540334
- Mean Citation Score: 373.708054
- Max Citation Score: 386.97614
- Similarity Product: 286.1082569123125

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test